
Tamsulosin (0.4mg) + Dutasteride (0.5mg)
Active composition
+1 more active ingredient
Tamsulosin selectively antagonizes alpha-1 adrenergic receptors in the prostate and bladder neck, leading to smooth muscle relaxation and improved urine flow.
Dutasteride inhibits both type I and type II 5-alpha reductase enzymes, decreasing DHT levels and prostate growth.
Medical applications
Floapt-D Tablet MR is a combination medication containing Tamsulosin 0.4mg and Dutasteride 0.5mg, primarily prescribed for the treatment of benign prostatic hyperplasia (BPH), a condition characterized by an enlarged prostate gland causing urinary difficulties. Tamsulosin is an alpha-1 adrenergic receptor antagonist that works by relaxing the muscles in the prostate and bladder neck, thereby improving urine flow and reducing symptoms such as difficulty in starting urination, weak stream, and frequent urination. Dutasteride is a 5-alpha-reductase inhibitor that reduces the production of dihydrotestosterone (DHT), a hormone responsible for prostate growth, helping to shrink the enlarged prostate over time and prevent further progression of BPH. The modified-release (MR) formulation ensures a gradual release of the active ingredients, maintaining steady blood levels and enhancing therapeutic efficacy while minimizing side effects. Floapt-D is typically administered once daily and should be taken as directed by a healthcare professional. Common side effects may include dizziness, headache, or ejaculation disorders, and patients should be monitored for any adverse reactions. This combination therapy offers a dual mechanism approach, addressing both the symptoms and underlying causes of BPH, improving quality of life for affected individuals.
Dosage information not available. Please consult your doctor or pharmacist.
Important precautions
Based on clinical trials and patient reports.
Overall Tolerance
Common Side Effects
Information regarding the use of Floapt-D Tablet MR during pregnancy is not available. Please consult your doctor.
High Risk
Information regarding the use of Floapt-D Tablet MR during breastfeeding is not available. Please consult your doctor.
Medical Advice
There is limited information available on the use of Floapt-D Tablet MR in patients with kidney disease. Please consult your doctor.
Exercise Caution
Floapt-D Tablet MR may decrease alertness, affect your vision or make you feel sleepy and dizzy. Do not drive if these symptoms occur.
Consult Doctor
Floapt-D Tablet MR should be used with caution in patients with liver disease. Dose adjustment of Floapt-D Tablet MR may be needed. Please consult your doctor. Use of Floapt-D Tablet MR is not recommended in patients with severe liver disease.
Regular Checkup
0 reviews for Floapt-D Tablet MR

Tamsulosin (0.4mg) + Dutasteride (0.5mg)
Cheaper alternative availability
This medicine doesn't have a cheaper alternative with the same composition. Our health advisors can help you find other savings options based on your prescription.
Active composition
+1 more active ingredient
Tamsulosin selectively antagonizes alpha-1 adrenergic receptors in the prostate and bladder neck, leading to smooth muscle relaxation and improved urine flow.
Dutasteride inhibits both type I and type II 5-alpha reductase enzymes, decreasing DHT levels and prostate growth.
Medical applications
Floapt-D Tablet MR is a combination medication containing Tamsulosin 0.4mg and Dutasteride 0.5mg, primarily prescribed for the treatment of benign prostatic hyperplasia (BPH), a condition characterized by an enlarged prostate gland causing urinary difficulties. Tamsulosin is an alpha-1 adrenergic receptor antagonist that works by relaxing the muscles in the prostate and bladder neck, thereby improving urine flow and reducing symptoms such as difficulty in starting urination, weak stream, and frequent urination. Dutasteride is a 5-alpha-reductase inhibitor that reduces the production of dihydrotestosterone (DHT), a hormone responsible for prostate growth, helping to shrink the enlarged prostate over time and prevent further progression of BPH. The modified-release (MR) formulation ensures a gradual release of the active ingredients, maintaining steady blood levels and enhancing therapeutic efficacy while minimizing side effects. Floapt-D is typically administered once daily and should be taken as directed by a healthcare professional. Common side effects may include dizziness, headache, or ejaculation disorders, and patients should be monitored for any adverse reactions. This combination therapy offers a dual mechanism approach, addressing both the symptoms and underlying causes of BPH, improving quality of life for affected individuals.
Dosage information not available. Please consult your doctor or pharmacist.
Important precautions
Based on clinical trials and patient reports.
Overall Tolerance
Common Side Effects
Information regarding the use of Floapt-D Tablet MR during pregnancy is not available. Please consult your doctor.
High Risk
Information regarding the use of Floapt-D Tablet MR during breastfeeding is not available. Please consult your doctor.
Medical Advice
There is limited information available on the use of Floapt-D Tablet MR in patients with kidney disease. Please consult your doctor.
Exercise Caution
Floapt-D Tablet MR may decrease alertness, affect your vision or make you feel sleepy and dizzy. Do not drive if these symptoms occur.
Consult Doctor
Floapt-D Tablet MR should be used with caution in patients with liver disease. Dose adjustment of Floapt-D Tablet MR may be needed. Please consult your doctor. Use of Floapt-D Tablet MR is not recommended in patients with severe liver disease.
Regular Checkup
0 reviews for Floapt-D Tablet MR















